VAFP
ABBV icon

Vahanian & Associates Financial Planning’s AbbVie ABBV Stock Holding History

Vahanian & Associates Financial Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,539
Closed -$479K – 61
2021
Q4 		$479K Buy
+3,539
New +$418K 0.39% 70

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vahanian & Associates Financial Planning's ABBV Position: Q1 2022 in Review

Vahanian & Associates Financial Planning sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 3,539 shares — an estimated $479K sold.

Vahanian & Associates Financial Planning first reported a position in ABBV in Q4 2021 and held it in 1 quarter. The position peaked at $479K in Q4 2021. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Vahanian & Associates Financial Planning reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Vahanian & Associates Financial Planning sold 3,539 AbbVie shares in Q1 2022, an estimated $479K.
  • Vahanian & Associates Financial Planning first reported a position in AbbVie in Q4 2021 and held it in 1 quarter.
  • Vahanian & Associates Financial Planning's AbbVie position peaked at $479K in Q4 2021.
  • 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Vahanian & Associates Financial Planning's 13F filing for Q1 2022, filed 27 Apr 2022.